Professional analysis of whether Ribociclib is a chemotherapy drug or a targeted drug

Ribociclib is a targeted drug, not a chemotherapy drug in the traditional sense. It is an oral small molecule selective cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor. It mainly exerts anti-cancer effects by blocking key regulatory proteins in the tumor cell cycle. Compared with traditional chemotherapy drugs, Riboxiclib is more precise and targeted. It mainly acts on the proliferation mechanism of cancer cells rather than directly killing cells, so its side effects are relatively small.

As a CDK4/6 inhibitor, ribociclib inhibits CDK4 and CDK6 activity, blocking the progression of the cell cycle from the G1 phase into the S phase, thus preventing the proliferation and spread of cancer cells. This mechanism is different from the cytotoxic killing of chemotherapy drugs, which usually directly leads to cell death by damaging DNA or interfering with microtubule formation. Riboxiclib's targeting mechanism enables it to show significant efficacy in the treatment of hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer.

In clinical practice, ribociclib is usually used in combination with endocrine therapy drugs (such as letrozole) to further enhance the inhibitory effect on tumor cells. This combination regimen has become the first-line treatment option for HR+/HER2- advanced breast cancer, significantly extending the progression-free survival of patients. Compared with traditional chemotherapy, ribociclib combined with endocrine therapy has milder side effects, is better tolerated by patients, and maintains a higher quality of life.

In general, as a targeted therapy drug, Riboxiclib provides a more effective and safer treatment strategy than traditional chemotherapy by precisely intervening in the cell cycle regulation of tumor cells. Its emergence has enriched the treatment methods for breast cancer, reflected the development direction of precision medicine, and has become an important member of modern tumor treatment.

Reference materials:https://us.kisqali.com/